In May 2006 Illumina signed a deal to help DeCode Genetics find genes for common diseases.
Merck's recent deal with DeCode Genetics is a bet that there are genes that make people fat.
In its hunt for disease genes, Celera is racing against Perlegen Sciences, Decode Genetics and numerous academic labs.
Now an experimental drug from Iceland's DeCode Genetics shows promise of quelling heart inflammation in a preliminary human trial.
Decode Genetics makes headlines for its pioneering discoveries linking genes to heart disease, cancer, diabetes and other deadly diseases.
Chalk it up to the initiative of one man, a 6-foot-5 Viking named Kari Stefansson, who founded DeCode Genetics Inc. in Reykjavik two years ago.
On Sept. 27, Merck made a bet that obesity has its roots in genetics by signing a deal with Iceland's DeCode Genetics .
Unable to land government grants for his proposal to study Icelanders' genetics, Stefansson left Harvard and founded DeCode Genetics in Reykjavik in 1996.
DeCODE Genetics, based in Reykjavik, Iceland, today is launching a new service that that it says will provide a detailed personal genetic profile.
DeCode Genetics announced this morning that it had found a gene linked to obesity, prompting a milestone payment from its partner Merck .
Patient groups are sponsoring drug discovery at other firms, including Iceland's Decode Genetics and England's Oxford BioMedica, which is plying a gene-therapy approach.
Among them are Google (nasdaq: GOOG - news - people )-funded 23andMe, Iceland's Decode Genetics and Navigenics of Redwood Shores, California.
Among them are Google (nasdaq: GOOG - news - people )-funded 23andMe, Iceland's Decode Genetics and Navigenics of Redwood Shores, Calif.
And it was this location that led to his first contacts with DeCode Genetics founder Kari Stefansson , then a professor at Harvard University.
Chalk it up to the initiative of one man, towering Viking named Kari Stefansson, who founded DeCode Genetics Inc. in Reykjavik two years ago.
In a step towards the long-awaited era of personalized medicine, Iceland's DeCode Genetics has discovered a new genetic risk factor for the bone-thinning disease osteoporosis.
Numerous companies including 23andme, Decode Genetics, and Navigenics, now sell gene tests or gene scans that purport to identify your risk of various common diseases.
Navigenics, Iceland's DeCode Genetics and 23andMe, whose investors include Google and Genentech, use DNA chips to give people preliminary data on their risk of a variety of diseases.
For smaller companies like AtheroGenics or DeCode Genetics, or even for giants like GlaxoSmithKline without so much skin in the game, it may be much more difficult to keep up.
Researchers at Decode Genetics in Iceland have found two genes in Icelanders that appear to improve the chances of living past 90 by protecting brain cells from damage and disease.
In contrast, a genomics firm like Iceland's DeCode Genetics (nasdaq: DCGN - news - people ) might apply for 350 gene patents--as DeCode did today--that might make money someday, but still post a loss.
On Jan. 15, Pharmacia announced an alliance with Reykjavik, Iceland-based DeCode Genetics (nasdaq: DCGN - news - people ) to find genes that predispose people to progress from early forms of heart disease to later ones.
DeCODE Genetics is competing with a number of companies that plan to offer personalized genome info, including 23andMe and Navigenics. 23andMe was co-founded by the new wife of Google co-founder SergeyBrinSergey Brin, Anne Wojcicki, and has backing from Google and Genentech.
Case in point: On Monday, DeCode Genetics published an important genetic map--assembled by methods very different from those used to create the sequence of the human genome--that will make it much easier for scientists to hunt down new genes linked to disease.
With the technology racing along so fast, entrepreneurs have jumped aboard the bandwagon to offer members of the public tantalising glimpses of what their genes may have in store for them. 23andMe of Mountain View, California, and deCode Genetics of Iceland started last November.
Artery drugs being developed by DeCode Genetics (nasdaq: DCGN - news - people ), GlaxoSmithkline (nasdaq: GSK - news - people ) and AtheroGenics (nasdaq: AGIX - news - people ) target artery inflammation, a more vague target, and hence a harder sell.
DeCODE Genetics (nasdaq: DCGN - news - people ) is competing with a number of companies that plan to offer personalized genome info, including 23andMe and Navigenics. 23andMe was co-founded by the new wife of Google (nasdaq: GOOG - news - people ) co-founder Sergey Brin , Anne Wojcicki, and has backing from Google and Genentech.
It includes DeCode Genetics (nasdaq: DCGN - news - people), the company that made news with its plan to use the genealogy of the people of Iceland as a tool for genetic research, and Exelixis (nasdaq: EXEL - news - people), which uses model systems like fruit flies to figure out what genes do in human beings.
"This is the first glimpse of what the new genetics is going to give us, " says DeCode Chief Executive Dr. Kari Stefansson .
DeCode is a small, unprofitable biotech firm founded by the genetics visionary Kari Stefansson , who left a tenured post at Harvard University to go back to Iceland and probe the genetics of an entire country.
应用推荐